Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Defective glycosylation in muscular dystrophy

Muntoni, Francesco, Brockington, Martin, Blake, Derek J., Torelli, Silvia and Brown, Susan C. 2002. Defective glycosylation in muscular dystrophy. The Lancet 360 (9343) , pp. 1419-1421. 10.1016/S0140-6736(02)11397-3

Full text not available from this repository.

Abstract

Context Over the past 15 years the causative genes of several inherited muscular dystrophies have been identified. These genes encode sarcolemmal, extracellular matrix, sarcomeric, and nuclear envelope proteins. Although the post-translational processing of muscle proteins has a significant role in their correct assembly and function, these processes have not been shown to be primarily involved in the pathogenesis of muscular dystrophies until recently. In the past 18 months, four different forms of inherited muscular dystrophy in human beings have been associated with mutations in genes encoding for putative glycosyltransferases. Aberrant glycosylation of α-dystroglycan, an external membrane protein expressed in muscle, brain, and other tissues, is a common feature in these disorders. α-dystroglycan is highly glycosylated, its sugar components varying in different tissues and controlling its interaction with extracellular matrix partners. Disrupted glycosylation of α-dystroglycan results in a loss of these interactions, giving rise to both progressive muscle degeneration and abnormal neuronal migration in the brain. Starting point Kevin Campbell and colleagues have recently demonstrated that patients with muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD), as well as the myodystrophy (myd) mouse, have an abnormally glycosyated form of α-dystroglycan (Nature 2002; 418: 417–22 and 422–25). The abnormally glycosylated protein did not bind to three of its extracellular matrix ligands, laminin α2 chain, agrin, and neurexin. The investigators also showed that a neuronal migration disorder occurs in both the myd mouse and in a brain-restricted α-dystroglycan knock-out mouse that is similar to that seen in patients with MEB and FCMD. These results identify α-dystroglycan as having an essential role in both muscle and brain development and function. Where next Emphasis is moving away from identifying the protein components of the muscle fibre that are involved in muscular dystrophies towards the post-translational processing of proteins and the enzymes involved in these modifications. This opens up new avenues of research. Abnormal glycosylation of α-dystroglycan may underlie other as yet uncharacterised forms of muscular dystrophy and neuronal migration disorders.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Subjects: R Medicine > R Medicine (General)
Publisher: Elsevier
ISSN: 0140-6736
Last Modified: 04 Jun 2017 05:10
URI: http://orca-mwe.cf.ac.uk/id/eprint/49195

Citation Data

Cited 130 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item